Across TCGA pan-cancer cohorts, DDX18P3 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated DDX18P3 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher DDX18P3 RNA is associated with better overall survival. In most high-consensus cancer types, elevated DDX18P3 expression acts as an unfavorable survival marker, although some lineages such as BLCA and UCS show a favorable association.
BLCA, UCS, and CHOL are the cancer types where DDX18P3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.